← Back to Search

Behavioural Intervention

Dignity Therapy for End of Life

N/A
Waitlist Available
Led By William E Rosa, Ph.D., MBE, NP
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

"This trial aims to see if dignity therapy is effective for LGBTQ+ patients in hospice care. Dignity therapy involves patients sharing their life stories to create a document that can be shared with family."

Who is the study for?
This trial is for adult sexual and gender minority (SGM) patients, including LGBTQ+ individuals, who are in hospice care. They must be able to speak English and willing to participate in the therapy sessions in English. Patients with delirium or altered mental status that prevents them from giving consent cannot join.Check my eligibility
What is being tested?
The study is testing dignity therapy—a type of psychotherapy designed for SGM hospice patients. It involves discussing their life stories to create a legacy document that can be shared with loved ones, aiming to see if it's practical and effective at end of life.See study design
What are the potential side effects?
Dignity therapy does not involve medications or medical procedures, so traditional physical side effects are not expected. Emotional discomfort may arise when discussing personal history and reflecting on one’s life.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
the number of patients who complete the intervention

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dignity TherapyExperimental Treatment1 Intervention
The DT intervention is a 45-75-minute virtual interview, which is recorded and transcribed within 72-96 hours of the interview.

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,935 Previous Clinical Trials
588,840 Total Patients Enrolled
William E Rosa, Ph.D., MBE, NPPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are potential participants currently able to apply for enrollment in this research study?

"Based on information from clinicaltrials.gov, it appears that this particular research study is currently not in the recruitment phase. While initially shared on January 29, 2024 and most recently revised on February 27, 2024, there are still numerous other studies actively seeking participants – approximately 83 trials as of now."

Answered by AI
~10 spots leftby Jan 2026